echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Harbin actively constructs the development pattern of "1 + n" biomedical industry

    Harbin actively constructs the development pattern of "1 + n" biomedical industry

    • Last Update: 2017-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network industry trends] in recent years, in order to promote the supply side structural reform and promote the healthy development of biomedical industry, Harbin city has attracted social capital to participate in the construction of characteristic parks through market-oriented operation; Actively strive to be included in the pilot program of drug listing license holder system, support the cooperation between biomedical enterprises and drug listing license holders, and give a one-time reward of 2 million yuan to each enterprise for production in Harbin and annual output value of more than 100 million yuan In addition, for the biomedical industry projects listed in the priority Industrial Catalogue of Heilongjiang Province and with intensive land use, when determining the land transfer price, the price shall be no less than 70% of the lower limit price of the corresponding industrial land of the land grade (picture source: Baidu picture) the reporter learned from the municipal development and Reform Commission that in order to promote the supply side structural reform and build a new modern industrial system, Harbin recently implemented several policies to promote the healthy development of the biomedical industry, with a validity period of 5 years According to the "several policies", our city will rely on the Limin Pharmaceutical Industrial Park of Harbin new area to establish the Municipal Office for promoting the biomedical industry, which is responsible for promoting the development of the biomedical industry; We will formulate and implement the "1 + n" development strategy, take the pharmaceutical industrial park for the benefit of the people as the core area, and build a unified planning, dislocation development, complementary advantages and multi-point support pattern for the development of the biomedical industry, which is composed of one core area and N characteristic Parks In addition to Pingfang District, Songbei district and Wuchang City, the characteristic Park shall be declared by each district / county (city) and determined after expert review and approval by the municipal government If the annual sales revenue exceeds 100 million yuan, 80% of the contribution increment can be returned to Harbin city to attract social capital to participate in the park construction through market-oriented operation Actively develop industrial real estate, encourage to carry out plant agent construction and rental buyback services for investment projects, and the enterprise shall buy back the property rights according to the agreed price and time limit At the same time, Harbin will set up a biomedical industry development fund for R & D services such as park infrastructure and plant construction, equity and debt investment, technology transfer, M & a guidance and high-level talent introduction In the future, biomedical industry projects listed in the list of provincial and municipal key projects, with good market prospects and in urgent need of working capital can apply for loan guarantee from state-owned policy guarantee institutions, and the loan funds shall be used exclusively for closed operation The project shall be applied by each industrial park and reviewed and supervised by the municipal bio pharmaceutical industry promotion office Harbin will also actively strive for the support of the province to help Biopharmaceutical Enterprises include the products that meet the requirements in the medical insurance catalog Harbin encourages District, county and city governments to speed up the development of local economic industries Take 2016 as the base year, expand the production and sales scale of the existing and newly introduced biomedical Enterprises above the designated size and those above the designated size and those above the designated size and those above the designated size, and increase the annual sales revenue of RMB 100 million to RMB 500 million (including RMB 100 million and excluding RMB 500 million, the same below), RMB 500 million to RMB 1 billion, and the annual sales revenue of RMB 1 billion For those above 100 million yuan, 80%, 85% and 90% of the incremental contribution of the above-mentioned enterprises to the local economic development will be awarded to the District, county (city) government for overall planning to support the local economic and industrial development After the varieties of biomedical enterprises that have passed the national consistency evaluation are put into production, a one-off reward of 30% of the actual investment and up to 3 million yuan will be given B according to several policies, Harbin actively strives to be included in the pilot of drug listing license holder system, supports the cooperation between biomedical enterprises and drug listing license holders, and gives a one-time reward of 2 million yuan to each enterprise for its production and annual output value of more than 100 million yuan A one-time reward of 5 million yuan will be given to the new technological innovation platform and public service platform of biomedical industry in Harbin For the innovative drugs, improved new drugs and first generic drugs (three types of medical devices with independent intellectual property rights refer to the implementation), after 2016, those who apply for obtaining clinical approval documents and carrying out clinical trials will be rewarded with 2 million yuan; after 2016, those who apply for obtaining production approval documents and carrying out production will be rewarded with 5 million yuan For the biomedical industrialization projects supported by the state in 2017 and later, after the acceptance, the post subsidy method is adopted to provide supporting fund support according to 50% of the state support fund, which is no more than 5 million yuan C the land transfer fee for the eligible projects is based on the preferential basis of several policies For the biomedical industry projects listed in the priority Industrial Catalogue of our province and with intensive land use, when determining the land transfer price, the price shall be no less than 70% of the lower limit price of the corresponding industrial land corresponding to the local land grade If it is difficult to pay the land transfer fee in lump sum, it may be paid in installments in accordance with the contract for the assignment of the right to the use of state owned construction land The "agency system" shall be implemented for biomedical industry projects in line with the park's planning In terms of project approval, planning, land and environmental impact assessment, the city, district and county (city) shall set up a special service agency to handle the early formalities in full time As a whole, the total amount of the above-mentioned awards, subsidies and supporting funds in several policies shall not exceed 100% of the incremental contribution of enterprises to local economic development.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.